ArticleStem cell reviews and reports2026
Mesoderm and myogenesis-related lncRNAs as Potential Markers of Myogenic Differentiation of Control and miR145 or miR181 Stimulated Mouse Pluripotent Stem Cells.
Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Non-coding RNAs play a crucial role in the regulation of gene expression, impacting all processes occurring in a living cell. Among them are microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), which interplay with each other modulating the expression of target genes. In the current study, we focused on lncRNAs described as involved in mesoderm specification or proliferation and differentiation of myogenic precursor cells and verified which of them may indeed be useful as candidate markers of mesodermal/myogenic differentiation of pluripotent stem cells (PSCs). As a model, we used two mouse embryonic stem cell (ESC) lines. We compared cells differentiating in the control medium with those induced to undergo myogenic differentiation by retinoic acid, insulin, transferrin, and selenium treatment. We showed that such induced ESC differentiation upregulated expression of few lncRNAs, i.e., yylncT, H19, SRA, and linc-YY1, in both lines. The expression of other analyzed lncRNAs changed in the ESC line specific manner. Next, we studied the impact of miR145 or miR181, which we have previously documented to elevate myogenic gene expression, on lncRNA levels. We found that miR145 overexpression resulted in decrease in H19 in both ESC types. Another common change observed in both cell lines was decrease of H19 in response to miR181. Again, the expression of most lncRNAs known as mesodermal and myogenic regulators and studied by us occurred in ESC line-dependent, and diverse manner. For the first time we verified if and which lncRNAs may serve as a potential indicators of up-and-coming myogenic differentiation. However, it should obviously be tested by extensive studies that include multiple different PSC lines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.